Literature DB >> 21652274

Mitochondrial DNA mutations and depletion in pediatric medicine.

A Spinazzola1.   

Abstract

Mitochondrial disorders are a group of diseases traditionally ascribed to defects of the respiratory chain, which is the only metabolic pathway in the cell that is under the control of the two separate genetic systems, the mitochondrial genome (mtDNA) and the nuclear genome (nDNA). Therefore the genetic classification of the primary mitochondrial diseases distinguishes disorders due to mutations in mtDNA, which are sporadic or maternal inherited, from disorders due to mutations in nDNA, which are governed by the stricter rules of mendelian genetics. Pathological alterations of mtDNA fall into two main categories: primary mutations of mitochondrial DNA (point mutations and rearrangements) and mtDNA perturbation, due to mutations in nuclear genes whose products are involved in mtDNA maintenance or replication. This article will focus on the primary mitochondrial DNA mutations and mtDNA depletion syndromes related to neonatal-infant human pathology.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652274     DOI: 10.1016/j.siny.2011.04.011

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  8 in total

1.  Mitochondrial Factors and VACTERL Association-Related Congenital Malformations.

Authors:  S Siebel; B D Solomon
Journal:  Mol Syndromol       Date:  2013-02

Review 2.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment.

Authors:  Dmitriy M Niyazov; Stephan G Kahler; Richard E Frye
Journal:  Mol Syndromol       Date:  2016-06-03

Review 3.  Use of Next-Generation Sequencing for Identifying Mitochondrial Disorders.

Authors:  Shafi Mahmud; Suvro Biswas; Shamima Afrose; Mohasana Akter Mita; Md Robiul Hasan; Mst Sharmin Sultana Shimu; Gobindo Kumar Paul; Sanghyun Chung; Md Abu Saleh; Sultan Alshehri; Momammed M Ghoneim; Maha Alruwaily; Bonglee Kim
Journal:  Curr Issues Mol Biol       Date:  2022-02-27       Impact factor: 2.976

Review 4.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 5.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

6.  Adult mitochondrial DNA depletion syndrome with mild manifestations.

Authors:  Josef Finsterer; Gabor G Kovacs; Uwe Ahting
Journal:  Neurol Int       Date:  2013-06-25

7.  MPV17 Mutations Are Associated With a Quiescent Energetic Metabolic Profile.

Authors:  Sandra Jacinto; Patrícia Guerreiro; Rita Machado de Oliveira; Teresa Cunha-Oliveira; Maria João Santos; Manuela Grazina; Ana Cristina Rego; Tiago F Outeiro
Journal:  Front Cell Neurosci       Date:  2021-03-17       Impact factor: 5.505

8.  The single nucleotide variant at c.662A>G in human RRM2B is a loss-of-function mutation.

Authors:  Yen-Tzu Tseng; Shang-Wei Li; Wei-Chun HuangFu; Yun Yen; I-Hsuan Liu
Journal:  Mol Genet Genomic Med       Date:  2020-09-15       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.